Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 MRI measures should be a primary outcome endpoint in Phase III randomized, controlled trials in multiple sclerosis: yes.

Literature DB >> 24589685

MRI measures should be a primary outcome endpoint in Phase III randomized, controlled trials in multiple sclerosis: yes.

Maria Pia Sormani¹, Nicola De Stefano.

Abstract

Entities: Disease

Mesh：

Year: 2014 PMID： 24589685 DOI： 10.1177/1352458513507360

Source DB: PubMed Journal: Mult Scler ISSN： 1352-4585 Impact factor: 6.312

Keyword Cloud
Cited

× No keyword cloud information.

3 in total

Review 1. Defining Disease Activity and Response to Therapy in MS.

Authors: Ulrike W Kaunzner; Mais Al-Kawaz; Susan A Gauthier
Journal: Curr Treat Options Neurol Date: 2017-05 Impact factor: 3.598

2. The Effect of Disease-Modifying Drugs on Brain Atrophy in Relapsing-Remitting Multiple Sclerosis: A Meta-Analysis.

Authors: Pierre Branger; Jean-Jacques Parienti; Maria Pia Sormani; Gilles Defer
Journal: PLoS One Date: 2016-03-16 Impact factor: 3.240

3. MRI FLAIR lesion segmentation in multiple sclerosis: Does automated segmentation hold up with manual annotation?

Authors: Christine Egger; Roland Opfer; Chenyu Wang; Timo Kepp; Maria Pia Sormani; Lothar Spies; Michael Barnett; Sven Schippling
Journal: Neuroimage Clin Date: 2016-11-20 Impact factor: 4.881

3 in total